Satellite Banner
Biomolecular Screening
Scientific Community
 
Join | Sign in
Home>Resources>Application Notes>This Application Note
  Application Notes
Scientific News
New Molecule Could Slow The Progression Of Parkinson’s
University of Bath researchers have designed a molecule that, if developed into a drug, could slow the progression of Parkinson's Disease.
Study Could Pave the Way for Painkillers with Fewer Side Effects
Research at SLAC explores promising alternative to morphine.
Single-Cell, 42-plexed Protein Analysis Achieved with a New Microchip Technology
A novel microdevice capable of detecting 42 unique immune effector proteins has been developed.
Possible Neuron Killing Mechanism Behind Alzheimer’s and Parkinson’s Diseases Discovered
$1.4 million grant will enable team to follow up with search for drug candidates.
MAGE Genes Provide Insight into Optimizing Chemotherapy
UT Southwestern Medical Center scientists have identified a new biomarker that could help identify patients who are more likely to respond to certain chemotherapies.
New Screening Tool Could Speed Development Of Ovarian Cancer Drugs
Researchers have built a 3D cell culture system which can help identify small molecules that could be used to treat ovarian cancer.
New Biomarkers To Spot Pancreatic Cancer Early
A combination of two biomarkers can identify pre-clinical pancreatic cancer.
Artificially-intelligent Robot Scientist ‘Eve’ Could Boost Search for New Drugs
Eve, an artificially-intelligent ‘robot scientist’ could make drug discovery faster and much cheaper, say researchers writing in the Royal Society journal Interface.
New Metabolic Biomarkers Predict Future Cardiovascular Diseases
Scientists of the Helmholtz Zentrum München contributed to the analysis of the biomarkers.
New Cancer-Fighting Strategy Would Harden Cells to Prevent Metastasis
Potential drug for pancreatic cancer now being tested in animals.

Tag-liteTM: New HTRF® cellular platform for cell surface receptors’ study and screening
Bookmark and Share
Cisbio Bioassays


For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here



Cisbio Bioassays and IGF Launch CNS Drug Discovery Research Program
Cisbio Bioassays, member of IBA Group and global provider of HTRF® (homogenous time resolved fluorescence) technology and services to facilitate drug discovery, has announced the launch of the GluSense research and development program in partnership with the Functional Genomics Institute of Montpellier, France.
Tuesday, November 30, 2010
Cisbio Bioassays Partners with Promega to Launch HaloTag® for Tag-lite®
Combination of HaloTag® and HTRF® technologies provides a new, flexible tool for cell surface receptor heterodimerization.
Thursday, September 23, 2010
Cisbio Bioassays Marks Second Milestone in China with new Demo Lab
Lab to support drug discovery customers in Asia by providing local training and services.
Thursday, July 22, 2010
Cisbio Bioassays Strengthens Presence in Asia
Global developer of drug screening tools and technologies now has local sales teams in China and South Korea.
Friday, November 06, 2009
Cisbio Bioassays Selects CyBio Robotic Workstation
The robotic workstation complements Cisbio’s expertise in creating and optimizing HTRF assays.
Wednesday, February 04, 2009
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters